Orygen: Clinical Trials

5 trials sponsored by Orygen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 11Completed 1
Phase 31Unknown 1

Follow Orygen: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Lidexamfetamine - Conduct Disorder
Phase 2Not yet recruitingOrygen302027-02-012026-11-06
Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety
Third wave VR therapy - Depression Anxiety Disorder
Phase 2Active not recruitingOrygen752025-04-012026-09-14
Guanfacine Extended-release for Adolescents With Cannabis Use
Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with alcohol and other drug services - Cannabis Use Disorder
Phase 2RecruitingOrygen1002023-07-272025-07-31
Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
omega-3 PUFAs, Standard care, placebo - 22q11 Deletion Syndrome
Phase 2 / Phase 3UnknownBambino Gesù Hospital and Research Institute802014-06-012014-02-25
Promotion of Self-help Strategies for Depression
Mood Memo emails - Depressive Disorder, Depression
Phase 1 / Phase 2CompletedOrygen17362011-11-012013-12-11

Conditions studied

Depression (2)  ·  22q11 Deletion Syndrome (1)  ·  Aggression (1)  ·  Anxiety Disorders (1)  ·  Conduct Disorder (1)  ·  Depressive Disorder (1)  ·  Psychotic Disorders (1)

Interventions

Ethanol (1)  ·  Fish Oils (1)  ·  Guanfacine (1)  ·  Standard of Care (1)

Countries

Australia (3)  ·  Holy See (1)

Top investigators

Alexandre A Guerin, PhD (1)  ·  Andrew J Mackinnon, PhD (1)  ·  Anthony F Jorm, PhD, DSc (1)  ·  Marco Armando, MD, PhD (1)

Results publications

PMID 23805231